OncoCyte Corporation

Historical 13F Holders

Symbol
IMDX
CUSIP
68235C206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68235C206 since 12/18/2024, newest first.

Filer % of Class Filed
Broadwood Partners, L.P. 13D/A Amendment 14
39.7% 4/27/2026
Event 4/23/2026
Broadwood Partners, L.P. 13D/A Amendment 13
37.4% 2/12/2026
Event 2/10/2026
AWM Investment Company, Inc. 13G/A Amendment 3 10.0% 5/9/2025
Event 3/31/2025
AWM Investment Company, Inc. 13G/A Amendment 2 7.5% 2/14/2025
Event 12/31/2024
Broadwood Partners, L.P. 13D/A Amendment 12
40.2% 2/10/2025
Event 2/6/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 915 k $3.28 M
2026 Q2 40 18.5 M $109 M
2026 Q1 41 18.9 M $62.1 M
2025 Q4 35 16.7 M $125 M
2025 Q3 28 16.3 M $54.1 M
2025 Q2 31 15.3 M $48.9 M
2025 Q1 30 16.0 M $49.1 M
2024 Q4 27 8.37 M $19.9 M
2024 Q3 23 7.11 M $20.3 M
2024 Q2 25 6.07 M $17.9 M
2024 Q1 28 3.81 M $11.2 M
2023 Q4 27 3.75 M $9.37 M
2023 Q3 29 3.72 M $11.6 M
2023 Q2 1 15.0 k $3.45 k